This is not the most recent version of the article. View current version (9 OCT 2015)

Intervention Protocol

You have free access to this content

Laser therapy for retinopathy in sickle cell disease

  1. Kay Thi Myint1,*,
  2. Soumendra Sahoo1,
  3. Soe Moe2,
  4. Han Ni3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 17 OCT 2013

DOI: 10.1002/14651858.CD010790


How to Cite

Myint KT, Sahoo S, Moe S, Ni H. Laser therapy for retinopathy in sickle cell disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010790. DOI: 10.1002/14651858.CD010790.

Author Information

  1. 1

    Melaka Manipal Medical College, Ophthalmology, Melaka, Malaysia

  2. 2

    Melaka-Manipal Medical College, Community Medicine, Melaka, Malaysia

  3. 3

    Melaka-Manipal Medical College, Internal Medicine, Melaka, Malaysia

*Kay Thi Myint, Ophthalmology, Melaka Manipal Medical College, Bukit Baru, Melaka, 75150, Malaysia. kaythimyint.eye@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2013

SEARCH

This is not the most recent version of the article. View current version (09 OCT 2015)

References

Additional references

Abiose 1978
  • Abiose A, Lesi FE. Ocular findings in children with homozygous sickle cell anaemia in Nigeria. Journal of Paediatric Ophthalmology and Strabismus 1978;15(2):92-5.
Ballas 2010
  • Ballas SK, Leiff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Definitions of phenotypic manifestations of sickle cell disease. American Journal of Haematology 2010;85(1):6-13. [DOI: 10.1002/ajh.21550]
Ballas 2012
  • Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier K, Osunkwo I, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. The Scientific World Journal http://www.hindawi.com/journals/tswj/2012/949535 (accessed 15 April 2013). [DOI: 10.1100/2012/949535]
Castro 1999
Cohen 1986
  • Cohen SB, Fletcher ME, Goldberg MF, Jednock NJ. Diagnosis and management of ocular complications of sickle haemoglobinopathies:part IV. Ophthalmic Surgery 1986;17(5):312-5.
Condon 1972
Condon 1974a
Condon 1974b
Cruess 1983
Deeks 2011
  • Deeks J, Higgins JPT, Altman D. Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011].The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Dineen 2008
  • Dineen B, Waldron-Lynch F, Harney F, Dinneen SF, Murphy A. Laser photocoagulation for diabetic retinopathy. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006960]
Downes 2005
  • Downes SM, Hambleton IR, Chuang EL, Lois N, Serjeant GR, Bird AC. Incidence and natural history of proliferative sickle cell retinopathy: observation from a cohort study. Ophthalmology 2005;112(11):1869-75.
Elagouz 2010
Emerson 2005
Emerson 2006
  • Emerson GE, Harlan JB, Fekrat S, Lutty GA, Goldberg MF. Hemoglobinopathies. In: Ryan SJ editor(s). Retina. 4th Edition. Vol. 2, Edinburgh: Elsevier, 2006:1429-45.
Erachulu 2006
  • Erachulu UV, Pam VA, Akuse RM. Ocular findings in children with severe clinical symptoms of homozygous sickle cell anaemia in Kaduna, Nigeria. West African Journal of Medicine 2006;25(2):88-91.
Fox 1991
Goldbaum 1979
Goldberg 1971
Goldberg 1983
  • Goldberg MF, Jampol LM. Treatment of neovascularization, vitreous haemorrhage and retinal detachment in sickle cell retinopathy. Transactions of the New Orleans Academy of Ophthalmology 1983;31:58-81.
Higgins 2011
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins PT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. Available from www.cochrane-handbook.org.
Hirst 2012
Kimmel 1986
  • Kimmel AS, Magagal LE, Stephens RS, Cruess AF. Peripheral circumferential retinal scatter photocoagulation for the treatment of proliferative sickle retinopathy. An update. Ophthalmology 1986;93(11):1429-34.
Lutty 1994
  • Lutty GA, Goldberg MF. Ophthalmologic complications. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH editor(s). Sickle cell disease: Basic principle and clinical practice. New York: Raven Press, 1994:703-24.
Marti-Carvajal 2012
  • Marti-Carvajal AJ, Knight-Madden JM, Martinez-Zapata MJ. Interventions for treating leg ulcers in people with sickle cell disease. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD008394.pub2]
Moriaty 1988
Rednam 1982
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2012.
Roberts 2007
Seiberth 2001
Serjeant 2001
Virgili 2009
  • Virgili G, Bini A. Laser photocoagulation for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004763.pub2]
Weatherall 2001
  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problems. Bulletin of the World Health Organization 2001;79(8):1-15.